Innovative therapies under clinical development for ALS treatment: small molecules.
Saved in:
| Title: | Innovative therapies under clinical development for ALS treatment: small molecules. |
|---|---|
| Authors: | Martinez-Gonzalez L; Biomedicine Department, Centro de Investigaciones Biologicas 'Margarita Salas'-CSIC, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Sanchez-Santos C; Biomedicine Department, Centro de Investigaciones Biologicas 'Margarita Salas'-CSIC, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Huang CS; Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, New Taipei City, Taiwan.; International Master Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, New Taipei City, Taiwan., Gil C; Biomedicine Department, Centro de Investigaciones Biologicas 'Margarita Salas'-CSIC, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Martinez A; Biomedicine Department, Centro de Investigaciones Biologicas 'Margarita Salas'-CSIC, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain. |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2026 May; Vol. 35 (5), pp. 351-367. Date of Electronic Publication: 2026 May 03. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42046889 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Innovative therapies under clinical development for ALS treatment: small molecules. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Martinez-Gonzalez+L%22">Martinez-Gonzalez L</searchLink>; Biomedicine Department, Centro de Investigaciones Biologicas 'Margarita Salas'-CSIC, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sanchez-Santos+C%22">Sanchez-Santos C</searchLink>; Biomedicine Department, Centro de Investigaciones Biologicas 'Margarita Salas'-CSIC, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Huang+CS%22">Huang CS</searchLink>; Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, New Taipei City, Taiwan.; International Master Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, New Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Gil+C%22">Gil C</searchLink>; Biomedicine Department, Centro de Investigaciones Biologicas 'Margarita Salas'-CSIC, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez+A%22">Martinez A</searchLink>; Biomedicine Department, Centro de Investigaciones Biologicas 'Margarita Salas'-CSIC, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229434197%22">Expert opinion on investigational drugs</searchLink> [Expert Opin Investig Drugs] 2026 May; Vol. 35 (5), pp. 351-367. <i>Date of Electronic Publication: </i>2026 May 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9434197 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213543784%22">13543784 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Investig Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42046889 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/13543784.2026.2667249 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 351 Titles: – TitleFull: Innovative therapies under clinical development for ALS treatment: small molecules. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Martinez-Gonzalez L – PersonEntity: Name: NameFull: Sanchez-Santos C – PersonEntity: Name: NameFull: Huang CS – PersonEntity: Name: NameFull: Gil C – PersonEntity: Name: NameFull: Martinez A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1744-7658 Numbering: – Type: volume Value: 35 – Type: issue Value: 5 Titles: – TitleFull: Expert opinion on investigational drugs Type: main |
| ResultId | 1 |
